Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Wednesday, October 30, 2019

The Echo Chamber

›
I just finished writing a commentary for Antimicrobial Agents and Chemotherapy entitled, The Economic Conundrum for Antibacterials. You ...
1 comment:
Monday, September 23, 2019

It's the Resistance, Stupid!

›
This is not the MRSA pandemic, ladies and gentlemen. Lets take a look at the MRSA pandemic. In  US hospitals, even today (latest CDC  data ...
2 comments:
Tuesday, September 17, 2019

Stuart Levy - A Giant in the Fight Against Resistance is Gone

›
Stuart Levy passed away last week after a long illness.  He was a friend, not a close friend, and a colleague.  I hadn’t spoken with him ...
1 comment:
Thursday, August 15, 2019

Incentives from Medicare?

›
The key problem for many struggling with the treatment of resistant infections and a paltry pipeline of new antibiotics has been the lack...
Thursday, July 18, 2019

Expert Societies Need to Step Up

›
I have a modest proposal that comes from my recent discussions with Brad Spellberg, Lew Barrett and John Rex. I am grateful to all three of...
2 comments:
Tuesday, July 16, 2019

Q&A with Brad Spellberg - Another Point of View Part 2

›
You noted that a subscription payment system such as the one recently proposed by the UK for purchases of low-volume use antibiotics would ...

Q&A with Brad Spellberg - Another Point of View - Part 1

›
Dr. Spellberg is an old friend and a co-author of a  recent  paper  (requires subscription or registration) from the New England Journal ...
1 comment:
‹
›
Home
View web version
Powered by Blogger.